Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry

Autor: Terry O’Brien, Patrick Kwan, Markus Reuber, Arjune Sen, Rhys Thomas, Lakshmi Nagarajan, Muhammad Zafar, Mark Keezer, Paul Lyons, George Morris, Andrea Andrade, David McCormick, Paolo Tinuper, Jorge Burneo, Michael Gelfand, Kristl Vonck, Yongjie Li, Kate Riney, Anto Bagic, Ryan Verner, James P Valeriano, Ricky Lee, Katarzyna Kotulska, Ellen Jespers, Maxine Dibué, Simon Harvey, Tim von Oertzen, Riem El Tahry, Andréa Julião deOliveira, Isabella D’Andrea Meira, Martin Veilleux, Kenneth Myers, GuoMing Luan, Fangcheng Li, JiWen Xu, Raja Sarma Gosala, Vrajesh Udani, Nilesh Kurwale, Michal Tzadok, Firas Fahoum, Hadassa Goldberg-Stern, Nicola Specchio, Seijiro Shimada, Tomonori Ono, Boudewijn Gunning, Louis Wagner, Rinze Neuteboom, Ewa Krzystanek, Youssef Al-Said, Mashael Omar Alkhateeb, Kasia Sieradzan, Jeffrey Cochius, Karen Keough, Marc Frost, Marie Collier, Kore Liow, Jane Boggs, Ahmed Sadek, James Wheless, James Valeriano, Linda Leary, Xiangping Zhou, Jose Ferreira, Gholam Motamedi, Masaki Iwasaki

Publikováno v: BMJ Neurology Open, Vol 3, Iss 2 (2021)

Introduction The Vagus Nerve Stimulation Therapy System (VNS Therapy) is an adjunctive neuromodulatory therapy that can be efficacious in reducing the frequency and severity of seizures in people with drug-resistant epilepsy (DRE). CORE-VNS aims to e

Externí odkaz: https://doaj.org/article/c8ce2a3830e94a4cab950ef777ac40d8